Clin2
NCT07724431Possibly a fitNot yet recruiting

Testing a new cholesterol-lowering drug in healthy adults

Overweight and Obesity

Part of Hormones & metabolism clinical trials.

This study tests a new drug called CG-0416 in healthy volunteers to see how safe it is and how the body handles it. The drug is given as a single dose or repeated doses, and researchers will monitor your health and cholesterol levels.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
64 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • You must be between 18 and 60 years old.
  • You need to be in good overall health, with no major medical conditions like diabetes, heart disease, or active thyroid problems.
  • Your body mass index (BMI) should be within certain limits (between 18 and 35, depending on the part of the study).
  • You must have a certain level of 'bad' cholesterol (LDL) in your blood.
  • If you could become pregnant or have a partner who could, you must agree to use reliable birth control during the study.
  • You agree to avoid certain substances, like alcohol, smoking, and strenuous exercise, during the study period.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07857473Not yet recruiting· Phase 2
Weight loss study for overweight or obese adults

This study tests an investigational drug called TE-8105 to see if it is safe and effective for helping adults who are overweight or obese lose weight. It may be an option for you if you are looking for a medical approach to weight management.

Leichhardt, New South Wales
NCT07437079Recruiting· Phase 1
Testing a new weight-loss medicine in healthy people

This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.

Lenexa, Kansas
NCT06867406Not yet recruiting· Phase 1
Safety study of a new tablet in healthy adults

This trial tests a new tablet drug in healthy people to see how safe it is and how the body processes it. It is an early-stage study, meaning it helps find the right dose and check for side effects.

Beijing, Beijing Municipality
NCT06252220Recruiting· Phase 1
Testing a new drug for obesity in healthy adults

This trial tests a new medication called DA-1726 for people with obesity but no other major health problems. It aims to see if the drug is safe and how it works in the body. You may qualify if your body mass index (BMI) is between 30 and 45 and your weight has been stable for 3 months.

Miami, Florida
NCT07001787Not yet recruiting· Phase 1
Safety of a new cholesterol-lowering pill in healthy adults

This study tests a new oral drug (HS-10510) in healthy people to check its safety and how the body handles it. It may help lower cholesterol, and some parts of the study look at how it works in people with higher cholesterol

NCT07722299Not yet recruiting· Phase 1
Safety study of SAL0167 in healthy adults

This study tests a new medication called SAL0167, which may help lower cholesterol, in healthy volunteers. It is a first-in-human study, meaning it looks at safety and how your body handles the drug, so it may not directly benefit your health but helps in developing a potential treatment for high cholesterol.

Guangzhou, Guangdong

Hear when a new Overweight and Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.